846 related articles for article (PubMed ID: 24623505)
1. Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis.
Toh ML; Bonnefoy JY; Accart N; Cochin S; Pohle S; Haegel H; De Meyer M; Zemmour C; Preville X; Guillen C; Thioudellet C; Ancian P; Lux A; Sehnert B; Nimmerjahn F; Voll RE; Schett G
Arthritis Rheumatol; 2014 Nov; 66(11):2989-3000. PubMed ID: 24623505
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis.
Paniagua RT; Chang A; Mariano MM; Stein EA; Wang Q; Lindstrom TM; Sharpe O; Roscow C; Ho PP; Lee DM; Robinson WH
Arthritis Res Ther; 2010; 12(1):R32. PubMed ID: 20181277
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.
Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH
Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544
[TBL] [Abstract][Full Text] [Related]
5. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
6. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis.
El Azreq MA; Boisvert M; Cesaro A; Pagé N; Loubaki L; Allaeys I; Chakir J; Poubelle PE; Tessier PA; Aoudjit F
J Immunol; 2013 Dec; 191(12):5941-50. PubMed ID: 24244022
[TBL] [Abstract][Full Text] [Related]
7. Experimental arthritis: Antibody against CSF-1 receptor protects bone and cartilage.
Onuora S
Nat Rev Rheumatol; 2014 May; 10(5):260. PubMed ID: 24686509
[No Abstract] [Full Text] [Related]
8. Necessity of lysophosphatidic acid receptor 1 for development of arthritis.
Miyabe Y; Miyabe C; Iwai Y; Takayasu A; Fukuda S; Yokoyama W; Nagai J; Jona M; Tokuhara Y; Ohkawa R; Albers HM; Ovaa H; Aoki J; Chun J; Yatomi Y; Ueda H; Miyasaka M; Miyasaka N; Nanki T
Arthritis Rheum; 2013 Aug; 65(8):2037-47. PubMed ID: 23666827
[TBL] [Abstract][Full Text] [Related]
9. Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis.
van Holten J; Reedquist K; Sattonet-Roche P; Smeets TJ; Plater-Zyberk C; Vervoordeldonk MJ; Tak PP
Arthritis Res Ther; 2004; 6(3):R239-49. PubMed ID: 15142270
[TBL] [Abstract][Full Text] [Related]
10. Brief report: amelioration of collagen-induced arthritis in mice by lentivirus-mediated silencing of microRNA-223.
Li YT; Chen SY; Wang CR; Liu MF; Lin CC; Jou IM; Shiau AL; Wu CL
Arthritis Rheum; 2012 Oct; 64(10):3240-5. PubMed ID: 22674011
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of junctional adhesion molecule-C in human and experimental arthritis.
Palmer G; Busso N; Aurrand-Lions M; Talabot-Ayer D; Chobaz-Péclat V; Zimmerli C; Hammel P; Imhof BA; Gabay C
Arthritis Res Ther; 2007; 9(4):R65. PubMed ID: 17612407
[TBL] [Abstract][Full Text] [Related]
12. META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis.
Konda VR; Desai A; Darland G; Bland JS; Tripp ML
Arthritis Rheum; 2010 Jun; 62(6):1683-92. PubMed ID: 20201075
[TBL] [Abstract][Full Text] [Related]
13. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis.
Raptopoulou AP; Bertsias G; Makrygiannakis D; Verginis P; Kritikos I; Tzardi M; Klareskog L; Catrina AI; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2010 Jul; 62(7):1870-80. PubMed ID: 20506224
[TBL] [Abstract][Full Text] [Related]
14. Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis.
Garcia S; Hartkamp LM; Malvar-Fernandez B; van Es IE; Lin H; Wong J; Long L; Zanghi JA; Rankin AL; Masteller EL; Wong BR; Radstake TR; Tak PP; Reedquist KA
Arthritis Res Ther; 2016 Mar; 18():75. PubMed ID: 27036883
[TBL] [Abstract][Full Text] [Related]
15. Intra-articular administration of an antibody against CSF-1 receptor reduces pain-related behaviors and inflammation in CFA-induced knee arthritis.
Alvarado-Vazquez PA; Morado-Urbina CE; Castañeda-Corral G; Acosta-Gonzalez RI; Kitaura H; Kimura K; Takano-Yamamoto T; Jiménez-Andrade JM
Neurosci Lett; 2015 Jan; 584():39-44. PubMed ID: 25301570
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis.
Krausz S; Garcia S; Ambarus CA; de Launay D; Foster M; Naiman B; Iverson W; Connor JR; Sleeman MA; Coyle AJ; Hamann J; Baeten D; Tak PP; Reedquist KA
Ann Rheum Dis; 2012 Aug; 71(8):1402-10. PubMed ID: 22730375
[TBL] [Abstract][Full Text] [Related]
17. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
Ishizuka Y; Moriwaki S; Kawahara-Hanaoka M; Uemura Y; Serizawa I; Miyauchi M; Shibata S; Kanaya T; Takata T; Taniguchi N; Niida S
J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
[TBL] [Abstract][Full Text] [Related]
18. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
[TBL] [Abstract][Full Text] [Related]
19. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
20. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes.
Gu X; Gu B; Lv X; Yu Z; Wang R; Zhou X; Qiao W; Mao Z; Zuo G; Li Q; Miao D; Jin J
Cell Death Dis; 2016 Oct; 7(10):e2423. PubMed ID: 27763638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
